Similar articles for PMID: 35093908

Year	Number of Results
2012	2
2013	3
2014	11
2015	12
2016	10
2017	18
2018	19
2019	17
2020	17
2021	9
2022	3
2023	2
2024	0

1

Ra-223 and Ethinylestradiol Combination Therapy in Castration-resistant Prostate Cancer.

Shimada T, Izumi K, Kano H, Kadomoto S, Makino T, Naito R, Iwamoto H, Yaegashi H, Kadono Y, Mizokami A. Shimada T, et al. Anticancer Res. 2022 Feb;42(2):1065-1071. doi: 10.21873/anticanres.15568. Anticancer Res. 2022. PMID: 35093908

2

Bone scan index can be a useful biomarker of survival outcomes in patients with metastatic castration-resistant prostate cancer treated with radium-223.

Naito M, Ukai R, Hashimoto K. Naito M, et al. Cancer Rep (Hoboken). 2019 Oct;2(5):e1203. doi: 10.1002/cnr2.1203. Epub 2019 Jun 30. Cancer Rep (Hoboken). 2019. PMID: 32721117 Free PMC article.

3

Radium-223 (Ra-223) Re-Treatment (Re-tx): First Experience From an International, Multicenter, Prospective Study in Patients (Pts) With Castration-Resistant Prostate Cancer and Bone Metastases (mCRPC).

[No authors listed] [No authors listed] Clin Adv Hematol Oncol. 2016 Apr;14(4 Suppl 5):10-1. Clin Adv Hematol Oncol. 2016. PMID: 27167843 Review. No abstract available.

4

Sequencing radium 223 and other life-prolonging agents in castration-resistant prostate cancer patients.

Caffo O, Frantellizzi V, Monari F, Sbrana A, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Palermo A, Fanti S, Biasco E, Murabito A, Filice A, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, Cortesi E, Vincentis G. Caffo O, et al. Future Oncol. 2021 Mar;17(7):807-815. doi: 10.2217/fon-2020-0391. Epub 2021 Jan 29. Future Oncol. 2021. PMID: 33508980

5

Sequencing Life-Prolonging Agents in Castration-Resistant Prostate Cancer Patients: Comparison of Sequences With and Without ²²³Ra.

Caffo O, Frantellizzi V, Monari F, Galli L, Costa RP, Pinto C, Tucci M, Baldari S, Facchini G, Bortolus R, Alongi F, Alongi P, Donner D, Fanti S, Sbrana A, Morabito A, Masini C, Zichi C, Pignata S, Borsatti E, Salgarello M, Spada M, De Giorgi U, Lo Re G, Cortesi E, De Vincentis G. Caffo O, et al. Cancer Biother Radiopharm. 2021 Jun;36(5):391-396. doi: 10.1089/cbr.2020.4442. Epub 2021 Mar 25. Cancer Biother Radiopharm. 2021. PMID: 33769088

6

Efficacy of Ethinylestradiol Re-challenge for Metastatic Castration-resistant Prostate Cancer.

Onishi T, Shibahara T, Masui S, Sugino Y, Higashi S, Sasaki T. Onishi T, et al. Anticancer Res. 2016 Jun;36(6):2999-3004. Anticancer Res. 2016. PMID: 27272817

7

Circulating Tumor Cells as a Biomarker of Survival and Response to Radium-223 Therapy: Experience in a Cohort of Patients With Metastatic Castration-Resistant Prostate Cancer.

Carles J, Castellano D, Méndez-Vidal MJ, Mellado B, Saez MI, González Del Alba A, Perez-Gracia JL, Jimenez J, Suárez C, Sepúlveda JM, Manneh R, Porras I, López C, Morales-Barrera R, Arranz JÁ. Carles J, et al. Clin Genitourin Cancer. 2018 Dec;16(6):e1133-e1139. doi: 10.1016/j.clgc.2018.07.013. Epub 2018 Jul 21. Clin Genitourin Cancer. 2018. PMID: 30104161

8

Review of Radium-223 and Metastatic Castration-Sensitive Prostate Cancer.

Dandapani SV, Wong J, Twardowski P. Dandapani SV, et al. Cancer Biother Radiopharm. 2020 Sep;35(7):490-496. doi: 10.1089/cbr.2019.3493. Epub 2020 Aug 6. Cancer Biother Radiopharm. 2020. PMID: 32762539 Review.

9

Phase II Clinical Study of Radium-223 Chloride (BAY 88-8223) in Japanese Patients With Symptomatic Castration-Resistant Prostate Cancer (CRPC) With Bone Metastases.

[No authors listed] [No authors listed] Clin Adv Hematol Oncol. 2016 Apr;14(4 Suppl 5):15-6. Clin Adv Hematol Oncol. 2016. PMID: 27167846 Review. No abstract available.

10

A randomized, double-blind, dose-finding, multicenter, phase 2 study of radium chloride (Ra 223) in patients with bone metastases and castration-resistant prostate cancer.

Parker CC, Pascoe S, Chodacki A, O'Sullivan JM, Germá JR, O'Bryan-Tear CG, Haider T, Hoskin P. Parker CC, et al. Eur Urol. 2013 Feb;63(2):189-97. doi: 10.1016/j.eururo.2012.09.008. Epub 2012 Sep 13. Eur Urol. 2013. PMID: 23000088 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

100 results

Results by year